Global In Vitro Fertilization Market
Global In Vitro Fertilization Market – Drivers, Restraints Opportunities, Trends, and Forecast up to 2024
Overview:
In Vitro Fertilization (IVF) is a process of fertilization that takes place outside the body, i.e., in vitro. IVF involves the production of eggs, i.e., superovulation, in women by medication and injecting hormones. The matured eggs are removed from ovary using oocyte aspiration systems, fertilized with the sperm of the donor, grown in a laboratory till it gets developed, and finally, the resulting embryo is implanted into the uterus. In recent years, PGD techniques are being used to screen the embryo for possible risk of passing on genetic disorders to offspring because one or both the partners may be carriers for a genetic disease. IVF also helps in maximizing the chance of conceiving in patients with a low ovarian reserve.
The in vitro fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the in vitro fertilization market.
Market Analysis: The “global in vitro fertilization market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, cycle types, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). Europe is the major shareholder in the global in vitro fertilization market, followed by North America. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology make Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.
Product Analysis: The in vitro fertilization market, by products, is segmented into reagents and instruments. Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others. The instruments segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period.
Cycle Type Analysis: The in vitro fertilization market, by cycle type, is segmented into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor IVF cycles. Fresh IVF cycles segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.
End-users Analysis: The in vitro fertilization market, by end-users, is segmented into hospitals and research laboratories, fertility and surgical centers, and cryobanks. Fertility and surgical centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.
Key Players:
Thermo Fisher Scientific, Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., ESCO Micro Pte Ltd., and niche players.
Competitive Analysis:
There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal is to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.
Benefits: The report provides complete details about the products offered by in vitro fertilization companies in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
Overview:
In Vitro Fertilization (IVF) is a process of fertilization that takes place outside the body, i.e., in vitro. IVF involves the production of eggs, i.e., superovulation, in women by medication and injecting hormones. The matured eggs are removed from ovary using oocyte aspiration systems, fertilized with the sperm of the donor, grown in a laboratory till it gets developed, and finally, the resulting embryo is implanted into the uterus. In recent years, PGD techniques are being used to screen the embryo for possible risk of passing on genetic disorders to offspring because one or both the partners may be carriers for a genetic disease. IVF also helps in maximizing the chance of conceiving in patients with a low ovarian reserve.
The in vitro fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the in vitro fertilization market.
Market Analysis: The “global in vitro fertilization market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, cycle types, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). Europe is the major shareholder in the global in vitro fertilization market, followed by North America. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology make Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.
Product Analysis: The in vitro fertilization market, by products, is segmented into reagents and instruments. Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others. The instruments segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period.
Cycle Type Analysis: The in vitro fertilization market, by cycle type, is segmented into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor IVF cycles. Fresh IVF cycles segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.
End-users Analysis: The in vitro fertilization market, by end-users, is segmented into hospitals and research laboratories, fertility and surgical centers, and cryobanks. Fertility and surgical centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.
Key Players:
Thermo Fisher Scientific, Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., ESCO Micro Pte Ltd., and niche players.
Competitive Analysis:
There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal is to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.
Benefits: The report provides complete details about the products offered by in vitro fertilization companies in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
1 INDUSTRY OUTLOOK
1.1 Industry overview
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of in vitro fertilization
3.3 Disadvantage of in vitro fertilization
3.4 Need of in vitro fertilization
3.5 Process of in vitro fertilization
3.6 Segmented Addressable Market (SAM)
3.7 Trends of the in vitro fertilization market
3.8 Related Markets
3.8.1 Female Condom market
3.8.2 Erectile dysfunction market
4 MARKET OUTLOOK
4.1 History of In Vitro Fertilization
4.2 Market segmentation
4.3 PEST Analysis
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global In Vitro Fertilization Market Dynamics
5.1.1 Drivers
5.1.1.1 Reducing fertility rates
5.1.1.2 Deferred pregnancies among women
5.1.2 Opportunities
5.1.2.1 Initiation from the government to promote IVF treatment
5.1.2.2 Increased fertility tourism
5.1.3 Restraints
5.1.3.1 High cost of IVF treatment
5.1.3.2 Low success rate of IVF treatment
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 PRODUCTS: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 By reagents
6.2.1 Cryopreservation media
6.2.2 Sperm processing media
6.2.3 Embryo culture media
6.2.4 Ovum processing media
6.3 By Instruments
6.3.1 Imaging system
6.3.2 Ovum aspiration pumps
6.3.3 Sperm separation systems
6.3.4 Micromanipulator systems
6.3.5 Incubators
6.3.6 Cryosystems
6.3.7 Others
7 BY CYCLE TYPE: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Fresh IVF cycle (Non-Donor)
7.3 Thawed IVF cycle (Non-donor)
7.4 Donor egg IVF cycles
8 BY END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals and research laboratories
8.3 Fertility and surgical centers
8.4 Cryobanks
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDOR PROFILES
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business focus
11.1.5 SWOT analysis
11.1.6 Business Strategy
11.2 Vitrolife
11.2.1 Overview
11.2.2 Geographic Presence
11.2.3 Business Focus
11.2.4 SWOT Analysis
11.2.5 Business Strategies
11.3 Cook Medical Inc.
11.3.1 Overview
11.3.2 Business Focus
11.3.3 SWOT Analysis
11.3.4 Business Strategies
11.4 Cooper Companies (CooperSurgical Inc.)
11.4.1 Overview
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
11.5 Irvine Scientific
11.5.1 Overview
11.5.2 Business Focus
11.5.3 SWOT Analysis
11.5.4 Business Strategy
12 COMPANIES TO WATCH FOR
12.1 Genea Limited
12.1.1 Overview
12.2 EMD Sereno, Inc.
12.2.1 Overview
12.3 ESCO Micro Pte Ltd
12.3.1 Overview
12.3.2 ESCO Micro Pte Ltd: Recent Developments
12.4 Hunter Scientific
12.4.1 Overview
12.5 OvaScience Inc
12.5.1 Overview
12.5.2 OvaScience Inc: Recent Developments
12.6 Oxford Gene Technology
12.6.1 Overview
12.6.2 Oxford Gene Technology: Recent Developments
13 ANNEXURE
13.1 Abbreviations
1.1 Industry overview
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Advantages of in vitro fertilization
3.3 Disadvantage of in vitro fertilization
3.4 Need of in vitro fertilization
3.5 Process of in vitro fertilization
3.6 Segmented Addressable Market (SAM)
3.7 Trends of the in vitro fertilization market
3.8 Related Markets
3.8.1 Female Condom market
3.8.2 Erectile dysfunction market
4 MARKET OUTLOOK
4.1 History of In Vitro Fertilization
4.2 Market segmentation
4.3 PEST Analysis
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 DRO – Global In Vitro Fertilization Market Dynamics
5.1.1 Drivers
5.1.1.1 Reducing fertility rates
5.1.1.2 Deferred pregnancies among women
5.1.2 Opportunities
5.1.2.1 Initiation from the government to promote IVF treatment
5.1.2.2 Increased fertility tourism
5.1.3 Restraints
5.1.3.1 High cost of IVF treatment
5.1.3.2 Low success rate of IVF treatment
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 PRODUCTS: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 By reagents
6.2.1 Cryopreservation media
6.2.2 Sperm processing media
6.2.3 Embryo culture media
6.2.4 Ovum processing media
6.3 By Instruments
6.3.1 Imaging system
6.3.2 Ovum aspiration pumps
6.3.3 Sperm separation systems
6.3.4 Micromanipulator systems
6.3.5 Incubators
6.3.6 Cryosystems
6.3.7 Others
7 BY CYCLE TYPE: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Fresh IVF cycle (Non-Donor)
7.3 Thawed IVF cycle (Non-donor)
7.4 Donor egg IVF cycles
8 BY END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals and research laboratories
8.3 Fertility and surgical centers
8.4 Cryobanks
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDOR PROFILES
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business focus
11.1.5 SWOT analysis
11.1.6 Business Strategy
11.2 Vitrolife
11.2.1 Overview
11.2.2 Geographic Presence
11.2.3 Business Focus
11.2.4 SWOT Analysis
11.2.5 Business Strategies
11.3 Cook Medical Inc.
11.3.1 Overview
11.3.2 Business Focus
11.3.3 SWOT Analysis
11.3.4 Business Strategies
11.4 Cooper Companies (CooperSurgical Inc.)
11.4.1 Overview
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
11.5 Irvine Scientific
11.5.1 Overview
11.5.2 Business Focus
11.5.3 SWOT Analysis
11.5.4 Business Strategy
12 COMPANIES TO WATCH FOR
12.1 Genea Limited
12.1.1 Overview
12.2 EMD Sereno, Inc.
12.2.1 Overview
12.3 ESCO Micro Pte Ltd
12.3.1 Overview
12.3.2 ESCO Micro Pte Ltd: Recent Developments
12.4 Hunter Scientific
12.4.1 Overview
12.5 OvaScience Inc
12.5.1 Overview
12.5.2 OvaScience Inc: Recent Developments
12.6 Oxford Gene Technology
12.6.1 Overview
12.6.2 Oxford Gene Technology: Recent Developments
13 ANNEXURE
13.1 Abbreviations
LIST OF TABLES
Table 1 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 2 OTHER PROMINENT VENDORS OF IN VITRO FERTILIZATION MARKET
Table 3 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
Table 4 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS
Table 5 VITROLIFE: OFFERINGS
Table 6 VITROLIFE: RECENT DEVELOPMENTS
Table 7 COOK MEDICAL INC.: PRODUCT OFFERINGS
Table 8 COOK MEDICAL INC: RECENT DEVELOPMENTS
Table 9 COOPER COMPANIES (COOPERSURGICAL INC.): OFFERINGS
Table 10 COOPER COMPANIES (COOPERSURGICAL INC): RECENT DEVELOPMENTS
Table 11 IRVINE SCIENTIFIC: PRODUCT OFFERINGS
Table 12 IRVINE SCIENTIFIC: RECENT DEVELOPMENTS
Table 13 GENEA LIMITED: SNAPSHOT
Table 14 GENEA LIMITED: RECENT DEVELOPMENTS
Table 15 EMD SERENO, INC.: SNAPSHOT
Table 16 EMD SERENO, INC.: RECENT DEVELOPMENTS
Table 17 ESCO MICRO PTE LTD: SNAPSHOT
Table 18 HUNTER SCIENTIFIC: SNAPSHOT
Table 19 OVASCIENCE: SNAPSHOT
Table 20 OXFORD GENE TECHNOLOGY: SNAPSHOT
Table 1 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION)
Table 2 OTHER PROMINENT VENDORS OF IN VITRO FERTILIZATION MARKET
Table 3 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
Table 4 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS
Table 5 VITROLIFE: OFFERINGS
Table 6 VITROLIFE: RECENT DEVELOPMENTS
Table 7 COOK MEDICAL INC.: PRODUCT OFFERINGS
Table 8 COOK MEDICAL INC: RECENT DEVELOPMENTS
Table 9 COOPER COMPANIES (COOPERSURGICAL INC.): OFFERINGS
Table 10 COOPER COMPANIES (COOPERSURGICAL INC): RECENT DEVELOPMENTS
Table 11 IRVINE SCIENTIFIC: PRODUCT OFFERINGS
Table 12 IRVINE SCIENTIFIC: RECENT DEVELOPMENTS
Table 13 GENEA LIMITED: SNAPSHOT
Table 14 GENEA LIMITED: RECENT DEVELOPMENTS
Table 15 EMD SERENO, INC.: SNAPSHOT
Table 16 EMD SERENO, INC.: RECENT DEVELOPMENTS
Table 17 ESCO MICRO PTE LTD: SNAPSHOT
Table 18 HUNTER SCIENTIFIC: SNAPSHOT
Table 19 OVASCIENCE: SNAPSHOT
Table 20 OXFORD GENE TECHNOLOGY: SNAPSHOT
LIST OF CHARTS
Chart 1 RESEARCH METHODOLOGY OF GLOBAL IN VITRO FERTLIZATION MARKET
Chart 2 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE, 2017–2024 ($MILLION)
Chart 3 SEGMENTATION OF GLOBAL IN VITRO FERTILIZATION MARKET
Chart 4 PEST ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET
Chart 5 PORTER 5 FORCES ON GLOBAL IN VITRO FERTILIZATION MARKET
Chart 6 DRO – IMPACT ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET
Chart 7 KEY STAKEHOLDERS
Chart 8 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2017 (%)
Chart 9 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2024 (%)
Chart 10 GLOBAL REAGENTS MARKET FORECAST, 2017–2024 ($MILLION)
Chart 11 GLOBAL REAGENTS MARKET SHARE, BY TYPE, 2017 (%)
Chart 12 GLOBAL INSTRUMENTS MARKET FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL INSTRUMENTS MARKET SHARE, BY TYPE, 2017 (%)
Chart 14 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2017 (%)
Chart 15 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2024 (%)
Chart 16 GLOBAL FRESH IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION)
Chart 17 GLOBAL THAWED IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION)
Chart 18 GLOBAL DONOR EGG IVF CYCLES MARKET FORECAST, 2017–2024 ($MILLION)
Chart 19 GLOBAL IN VITRO FERTILIZATION MARKET BY END USERS SEGMENTATION, 2017 (%)
Chart 20 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 21 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%)
Chart 22 IN VITRO FERTILIZATION MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 23 IN VITRO FERTILIZATION MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 24 IN VITRO FERTILIZATION MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 25 IN VITRO FERTILIZATION MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 26 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT
Chart 27 THERMO FISHER SCIENTIFIC INC: BUSINESS UNITS
Chart 28 THERMO FISHER SCIENTIFIC, INC.: GEOGRAPHIC PRESENCE
Chart 29 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
Chart 30 VITROLIFE: OVERVIEW SNAPSHOT
Chart 31 VITROLIFE: GEOGRAPHIC PRESENCE
Chart 32: SWOT ANALYSIS
Chart 33 COOK MEDICAL INC.: SWOT ANALYSIS
Chart 34 COOPER COMPANIES (COOPERSURGICAL INC.): OVERVIEW SNAPSHOT
Chart 35 COOPER COMPANIES (COOPERSURGICAL INC.): BUSINESS UNITS
Chart 36 COOPER COMPANIES (COOPERSURGICAL INC.): GEOGRAPHIC PRESENCE
Chart 37 COOPER COMPANIES (COOPERSURGICAL INC.): SWOT ANALYSIS
Chart 38 IRVINE SCIENTIFIC: SWOT ANALYSIS
Chart 1 RESEARCH METHODOLOGY OF GLOBAL IN VITRO FERTLIZATION MARKET
Chart 2 GLOBAL IN VITRO FERTILIZATION MARKET REVENUE, 2017–2024 ($MILLION)
Chart 3 SEGMENTATION OF GLOBAL IN VITRO FERTILIZATION MARKET
Chart 4 PEST ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET
Chart 5 PORTER 5 FORCES ON GLOBAL IN VITRO FERTILIZATION MARKET
Chart 6 DRO – IMPACT ANALYSIS OF GLOBAL IN VITRO FERTILIZATION MARKET
Chart 7 KEY STAKEHOLDERS
Chart 8 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2017 (%)
Chart 9 GLOBAL IN VITRO FERTILIZATION MARKET BY PRODUCT SEGMENTATION, 2024 (%)
Chart 10 GLOBAL REAGENTS MARKET FORECAST, 2017–2024 ($MILLION)
Chart 11 GLOBAL REAGENTS MARKET SHARE, BY TYPE, 2017 (%)
Chart 12 GLOBAL INSTRUMENTS MARKET FORECAST, 2017–2024 ($MILLION)
Chart 13 GLOBAL INSTRUMENTS MARKET SHARE, BY TYPE, 2017 (%)
Chart 14 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2017 (%)
Chart 15 GLOBAL IN VITRO FERTILIZATION MARKET BY CYCLE TYPE SEGMENTATION, 2024 (%)
Chart 16 GLOBAL FRESH IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION)
Chart 17 GLOBAL THAWED IVF CYCLE MARKET FORECAST, 2017–2024 ($MILLION)
Chart 18 GLOBAL DONOR EGG IVF CYCLES MARKET FORECAST, 2017–2024 ($MILLION)
Chart 19 GLOBAL IN VITRO FERTILIZATION MARKET BY END USERS SEGMENTATION, 2017 (%)
Chart 20 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%)
Chart 21 GLOBAL IN VITRO FERTILIZATION MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%)
Chart 22 IN VITRO FERTILIZATION MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION)
Chart 23 IN VITRO FERTILIZATION MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION)
Chart 24 IN VITRO FERTILIZATION MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION)
Chart 25 IN VITRO FERTILIZATION MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION)
Chart 26 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT
Chart 27 THERMO FISHER SCIENTIFIC INC: BUSINESS UNITS
Chart 28 THERMO FISHER SCIENTIFIC, INC.: GEOGRAPHIC PRESENCE
Chart 29 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
Chart 30 VITROLIFE: OVERVIEW SNAPSHOT
Chart 31 VITROLIFE: GEOGRAPHIC PRESENCE
Chart 32: SWOT ANALYSIS
Chart 33 COOK MEDICAL INC.: SWOT ANALYSIS
Chart 34 COOPER COMPANIES (COOPERSURGICAL INC.): OVERVIEW SNAPSHOT
Chart 35 COOPER COMPANIES (COOPERSURGICAL INC.): BUSINESS UNITS
Chart 36 COOPER COMPANIES (COOPERSURGICAL INC.): GEOGRAPHIC PRESENCE
Chart 37 COOPER COMPANIES (COOPERSURGICAL INC.): SWOT ANALYSIS
Chart 38 IRVINE SCIENTIFIC: SWOT ANALYSIS
